Oct 21, 2026 06:11AM

Oct 20, 2026 09:20PM

Sep 24, 2026 05:41AM

Sep 23, 2026 06:39AM

Sep 22, 2026 08:01AM

Sep 22, 2026 08:00AM

Sep 4, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)

Sep 3, 2026 04:03PM

Sep 3, 2026 03:52PM

Aug 20, 2026 07:00AM

Aug 20, 2026 07:00AM

Jul 29, 2026 07:05AM

Jul 29, 2026 07:05AM

Jul 29, 2026 07:00AM Ionis reports second quarter 2026 financial results and highlights progress on key programs

Jul 23, 2026 07:11AM

Jul 14, 2026 09:16AM

Jul 14, 2026 09:16AM

Jul 13, 2026 07:01AM

Jul 13, 2026 07:00AM

Jul 6, 2026 07:00AM

Jul 6, 2026 07:00AM Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome

Jun 25, 2026 07:12AM

Jun 25, 2026 06:48AM

Jun 25, 2026 03:33AM

Jun 25, 2026 02:59AM

Jun 25, 2026 02:59AM

Jun 24, 2026 02:39PM

Jun 24, 2026 02:37PM TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)

Jun 4, 2026 07:00AM

Jun 1, 2026 06:57AM

May 28, 2026 04:45AM

May 14, 2026 07:05AM

May 14, 2026 07:05AM

Apr 29, 2026 07:00AM

Apr 28, 2026 02:06AM FDA accepts GSK's bepirovirsen for priority review in hepatitis B treatment

Apr 28, 2026 02:06AM

Apr 21, 2026 07:03AM

Apr 21, 2026 07:00AM

Mar 30, 2026 07:30AM

Mar 30, 2026 07:30AM

Mar 23, 2026 07:00AM

Mar 23, 2026 07:00AM Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review

Mar 9, 2026 07:00AM

Mar 9, 2026 07:00AM

Mar 5, 2026 07:30AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 25, 2026 01:20PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Feb 25, 2026 07:00AM

334,713 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All